CAUSALab Clinics

What are the CAUSALab Clinics? 

The CAUSALab Clinics is a free causal inference consulting service offered to junior clinical investigators who are affiliated with Boston-area hospitals and who conduct research on the comparative effectiveness or safety of health interventions. Investigators are invited to present their works in progress, and postdoctoral fellows in the CAUSALab will offer their guidance and expertise with respect to: 

  • Study design (e.g., formulating a well-defined causal question, specifying the target trial) 
  • Data analysis (e.g., emulating the target trial, using g-methods) 
  • Interpretation of results 

One presenter will be invited for each session. We recommend that presenters prepare a 15-minute presentation (including an outline of the target trial that corresponds to the proposed research) with the remaining time allocated for questions and discussions. If selected, presenters are expected to be prepared with data, prior analyses, or any other relevant materials (ie. supplemental slides) before attending.  

When and where?

The CAUSALab Clinics are scheduled from 1 PM to 2 PM on selected Wednesdays at the Harvard T.H. Chan School of Public Health. In the 2023/24 academic year, CAUSALab Clinics will take place on the following days: 

  • September 27, 2023 
  • October 25, 2023 
  • November 15, 2023
  • December 13, 2023
  • January 24, 2024
  • February 21, 2024 
  • March 20, 2024 
  • April 17, 2024

How to Apply 

Complete this form to submit an online application. Applications will be reviewed on a rolling basis. If selected, you will be contacted to coordinate a presentation date.  

Questions? Please contact Joy Shi ( and Daniela van Santen ( 

Previous presentation topics:

  • Comparative effectiveness and safety of different cardiovascular interventions
  • Colchicine for limb preservation in peripheral artery disease
  • Impact of Medicare’s transitional care management program on clinical outcomes of patients after discharge home from the hospital
  • Challenges in estimating the comparative effectiveness of EEG-guided anti-seizure treatment in acute brain injury
  • Individualizing estimates of benefit and harm for older adults considering anticoagulants for atrial fibrillation
  • Utilizing instrumental variable approaches in evaluating the effectiveness of monoclonal antibodies in the treatment of asthma